JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

Search

West Pharmaceutical Services Inc

Gesloten

SectorGezondheidszorg

309.62 3.22

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

299.72

Max

309.74

Belangrijke statistieken

By Trading Economics

Inkomsten

6.7M

139M

Verkoop

40M

845M

K/W

Sectorgemiddelde

40.455

67.147

EPS

2.13

Dividendrendement

0.28

Winstmarge

16.428

Werknemers

10,800

EBITDA

-36M

174M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+9.93% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.28%

2.36%

Volgende Winsten

23 jul 2026

Volgende dividenddatum

6 mei 2026

Volgende Ex Dividend datum

29 jul 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.3B

21B

Vorige openingsprijs

306.4

Vorige sluitingsprijs

309.62

Nieuwssentiment

By Acuity

48%

52%

174 / 347 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

12 jan 2026, 11:40 UTC

Acquisities, Fusies, Overnames

AbbVie to Acquire Drug Delivery System, Arizona Manufacturing Facility from West Pharma

23 apr 2026, 16:47 UTC

Winsten

This Pharma Stock Is Soaring After Earnings. It's a Sneaky GLP-1 Play. -- Barrons.com

12 jan 2026, 11:02 UTC

Acquisities, Fusies, Overnames

AbbVie to Invest More Than $175 Million to Acquire, Modernize, Integrate Plant >ABBV WST

12 jan 2026, 11:01 UTC

Acquisities, Fusies, Overnames

AbbVie Plans to Hire About 200 Employees at Acquired Site >ABBV WST

12 jan 2026, 11:01 UTC

Acquisities, Fusies, Overnames

AbbVie To Buy Device Manufacturing Plant in Tempe, Ariz., Associated Intellectual Property From West >ABBV

12 jan 2026, 11:00 UTC

Acquisities, Fusies, Overnames

AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in U.S. >ABBV WST

Peer Vergelijking

Prijswijziging

West Pharmaceutical Services Inc Prognose

Koersdoel

By TipRanks

9.93% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 330 USD  9.93%

Hoogste 400 USD

Laagste 295 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor West Pharmaceutical Services Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

10 ratings

8

Buy

2

Hold

0

Sell

Technische score

By Trading Central

213.26 / 219.27Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

174 / 347 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat